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SUMMARY
Protein kinases control cellular responses to envi-
ronmental cues by swift and accurate signal pro-
cessing. Breakdowns in this high-fidelity capability
are a driving force in cancer and other diseases.
Thus, our limited understanding of which amino
acids in the kinase domain encode substrate
specificity, the so-called determinants of specificity
(DoS), constitutes a major obstacle in cancer
signaling. Here, we systematically discover several
DoS and experimentally validate three of them,
named the aC1, aC3, and APE-7 residues. We
demonstrate that DoS form sparse networks of
non-conserved residues spanning distant regions.
Our results reveal a likely role for inter-residue allo-
stery in specificity and an evolutionary decoupling
of kinase activity and specificity, which appear
loaded on independent groups of residues. Finally,
we uncover similar properties driving SH2 domain
specificity and demonstrate how the identification
of DoS can be utilized to elucidate a greater under-
standing of the role of signaling networks in cancer
(Creixell et al., 2015 [this issue of Cell]).
INTRODUCTION
Cellular organization and response to external and internal cues
relies on swift and precise processing of information through cell
signaling networks. High fidelity in these circuits depends
critically on the recognition and phosphorylation of specific sub-
strates by protein kinases, and perturbations of this cellular sys-
tem have been linked to significant evolutionary transitions
(Capra et al., 2012; Skerker et al., 2008; Tan et al., 2009; Zarrin-
par et al., 2003), as well as to disease progression, in particular,
in cancer (Borrello et al., 1995; Creixell et al., 2012; Marengere
et al., 1994; Santoro et al., 1995; Songyang et al., 1995).
Cellular signaling fidelity is maintained essentially through two
coupled mechanisms. At a macro-molecular level, protein spec-
ificity ensures that each protein kinase will reach and interact
with its protein substrates. At a micro-molecular or atomic level,
peptide specificity defines the ability of a given kinase domain
present in all active protein kinases to recognize and phosphor-
ylate a specific peptide within the protein substrate (Turk, 2008)
(Figure 1A). A variety of experimental techniques have been
developed to elucidate the peptide specificity for many modular
signaling domains and obtain specificity profiles (e.g., the so-
called Position-Specific Scoring Matrices, PSSMs), as a quanti-
tative measure of the preference of each kinase domain for each
amino acid residue at every peptide substrate position (Fig-
ure S1). While other factors contributing to protein interaction
specificity at a macro-molecular level (such as co-localization,
co-expression, docking motifs, and scaffold or adaptor proteins)
have been described (Bhattacharyya et al., 2006; Linding et al.,
2007; Reme´nyi et al., 2005; Scott and Pawson, 2009), the com-
bination of residues in the kinase domain that encode peptide
substrate specificity, the so-called determinants of specificity
(DoS), have remained largely elusive (Figure 1B). Even though
some structural studies have helped identify residues that are
in close contact with the substrate peptide which likely influence
specificity (Brinkworth et al., 2003; Ellis and Kobe, 2011; Hanks
and Hunter, 1995; Mok et al., 2010; Nolen et al., 2004), these
studies were largely focused on specific kinase families and/or
non-human species as well as limited in scope by the small
number of kinase-peptide structures currently available and an
inability to capture potentially long-range DoS.
Here, we present a computational approach that aims to
overcome these limitations and address the following open
questions. Which residues within the kinase domain contribute
to peptide specificity (constituting the so-called DoS)? Are
these determinants just a small group of residues localized in
close proximity to the substrate as currently thought, or do
they form a sparse network of residues instead (Figure 1C)?
Are such principles of domain-peptide specificity conserved in
other domains? Finally, how do these DoS relate, spatially and
functionally, to those residues known to be involved in the regu-
lation and catalytic activity of the kinase domain? In other
words, are these different functionalities loaded onto the same
residues or on independent groups of residues, and how did
they evolve?
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Figure 1. Open Questions in Protein Domain-Peptide Specificity
(A) Protein specificity determines the interaction between the whole kinase protein and its substrates and is driven by processes such as interactions between
other domains and motifs (e.g., SH2 and phospho-tyrosine in this figure), co-expression of the two proteins, cellular localization, scaffold proteins, etc.
(legend continued on next page)
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As we demonstrate in our accompanying article (Creixell et al.,
2015 [this issue of Cell]), which explores how cancer mutations
affect domain specificity by integrating the DoS identified here,
resolving these questions could represent a valuable contribu-
tion not only for basic signaling biology but also for cancer
research.
RESULTS
Learning about Residue Contributions to Specificity by
Sampling over Different Specificity Masks
When investigating the relationship between kinases at the
domain primary sequence similarity level and at the substrate
sequence motif similarity level (using specificity profiles or
PSSMs derived from Positional Scanning Peptide Library or
PSPL experiments, see Experimental Procedures and Fig-
ure S1), it is apparent that, when considering the domain in
its entirety, no strong linear correlation between these exists
(Figure S1). We hypothesized that this lack of correlation could
indicate that substrate specificity is not encoded by the domain
as a whole. Instead, we hypothesized that a limited number
of residues contribute to specificity, and that those that do
contribute, are likely to do so to different degrees. In order
to capture this principle, we introduced the specificity mask
as a fundamental entity in our approach. As depicted in Figures
1B and 2 (small box), a specificity mask is defined as a
particular combination of contributions to specificity from
the different residues in the kinase domain. For example, an
extreme hypothesis where all residues within the kinase domain
contribute equally to specificity would be represented by all
entries in a mask with the same score (e.g., 0.5). Instead, a
situation where a single residue, X, would drive specificity
would be represented by all entries scoring 0.0 except position
X scoring 1.0.
Our approach (described below) explores the possibility that
within a large ensemble of specificity masks, certain masks
can discriminate between kinases with dissimilar substrate
specificities better than others. These masks will range from
those capturing very few and localized DoS (reminiscent of
models explored in the structural studies; Brinkworth et al.,
2003; Ellis and Kobe, 2011; Hanks and Hunter, 1995; Mok
et al., 2010; Nolen et al., 2004) to those capturing a larger number
of determinants distributed more sparsely across the kinase
domain (Figure 1C). As further detailed in the next section, since
our aim was to identify new DoS following an unbiased data-
driven systematic approach, we did not impose any restrictions
in the set of specificity masks that can be found; instead, we
explore a large set of possible specificity masks and let the sys-
tem evolve and find those showing the best discriminatory
capabilities.
The KINspect Methodology
In order to identify which residues contribute to specificity, we
developed a computational framework named KINspect, which
explores a very large number of combinations of residues, and
their contribution toward specificity, and subsequently identifies
those featuring the best predictive capability (Figure 2). This type
of approach, known inmachine learningas learningclassifier sys-
tems (Lanzi et al., 2000), enables the selection of the best-per-
forming set of specificity masks starting from a large initial set
of randommasks by following three consecutive steps (Figure 2).
First, for each specificitymask, the specificity profiles (PSSMs)
for each kinase are predicted by comparing all kinases across the
human kinome at each amino acid position within the kinase
domain (amino acid similarity) and by incorporating a weighting
factor (from 0 to 1; 0 being not important, 1 being critical) of the
‘‘specificity importance’’ of each position as determined by the
given specificity mask. A PSSM for each kinase is then predicted
by integrating the PSSMs for the other kinases using the mask-
dependent similarity as a weighting factor. Naturally, themajority
of masks within the original set of random masks will predict
specificity poorly, but, as the system evolves, the masks will
improve their predictive power, i.e., become more fit.
Second,masks are ranked according to their predictive perfor-
mance (i.e., their ability to predict PSSMs that are similar to the
experimentally determined PSSMs). In essence, masks that
more closely capture the true contribution of each position within
the kinase domain (i.e., those scoring higher at kinase domain
positions that truly contribute to specificity) will result in a better
prediction of the specificity profiles, thus ranking higher.
Third, the worst-performing masks are filtered out and new
masks, representing both subtle (mutation) but also more abrupt
(cross-over) variations of the best-performing masks, will be
added.
These three steps are initially started with random specificity
masks and repeated until convergence is reached and fitness
cannot be optimized further. Residues consistently scoring
higher in the specificity masks following the optimization
procedure will be considered candidate DoS. For a more tech-
nical description of the algorithm, please refer to Figure 2 and
Extended Experimental Procedures.
Model Robustness, Validation, and Coverage
Since our method contains stochastic aspects (such as the
starting set of random masks and the generation of new masks
by mutation and cross-over), one initial question that must be
addressed is whether the method is robust to this initial stochas-
ticity, i.e., whether one would obtain similar results if the process
was started with arbitrary initial conditions and evaluated inde-
pendently several times. To this end, we compared the fitness
evolution of ten independent KINspect evaluations and found
(Bhattacharyya et al., 2006; Linding et al., 2007; Reme´nyi et al., 2005; Scott and Pawson, 2009). Peptide specificity, in contrast, is solely driven by the sequence
and structure of the kinase domain and drives the phosphorylation of specific linear motifs within the substrate protein.
(B) The so-called determinants of specificity (DoS) are those residues within a protein domain that together drive and determine the peptide specificity of the
domain.
(C) While relatively few localized DoS have been described in the kinase domain, this study explores the existence of more determinants and their relative domain
positions.
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highly comparable fitness trajectories, as well as increasing sim-
ilarity between the best-performing masks at each generation
(Figure S2; Data S1, S2, and S3). Moreover, we confirmed that
the results are not simply due to trivial technical factors, such
as residue conservation or alignment gaps (Figure S3), and
that similar results could not be obtained using uniform or
randomized sets (Figure S3). Taken together, these results
demonstrate that KINspect is robust to arbitrary initial conditions
and converges to a limited set of highly similar solutions (speci-
ficity masks, Figure S3).
Moreover, we also explored a vast number of possible combi-
nations of residues and specificity models. Since convergence in
the model requires approximately 2,500 cycles of the above
three steps (in the case of the human kinase domain) and 100
Figure 2. Overview of the KINspect Algorithm
The KINspect workflow is designed to identify the specificity mask that best describes the importance of the different residues for specificity. Different com-
binations of contributions to specificity by different kinase domain residues are collected as specificity masks (top left), where a score between 0 and 1 is given to
each position within the kinase domain. Originally, the specificity masks are initialized with random values to then follow a machine-learning procedure that will
ensure the masks with the highest predictive power toward specificity are selected for and optimized. This procedure, known as a learning classifier system, is
divided into three separate steps.
In step 1, for each specificity mask the system loops over all query kinases and, using a kinase domain alignment, compares the query kinase to all other kinases
(except those belonging to the same kinase family, which are excluded only at this stage to avoid over-fitting) at the sequence level, generating a similarity vector.
This vector is combined with the specificity mask, so that similarity in high-scoring positions of the mask is reinforced and similarity in low-scoring position of the
mask is silenced, effectively producing a mask-weighted similarity vector and sum score for each kinase. These values are subsequently used to integrate the
different observed PSSMs into a combined predicted PSSM for the query kinase (as further explained by the equations and text in Supplemental Experimental
Procedures section and in Zhang et al., 2009).
In step 2, after a predicted kinase has been generated for all the kinases in our set, fitness is computed as themedian of all the differences between the predicted
and the experimentally determined PSSM for all the kinases obtained from the NetPhorest repository (Miller et al., 2008).
In step 3, the best-performing specificitymasks are kept (‘‘elite’’), and new ones are generated bymutation (changing the value of a given position in themask) and
cross-over of the elite sequences (combining two segments of two other masks), as typically done in genetic algorithms. Once a new set of masks has been
generated, thewhole procedure (prediction, fitness evaluation, and generation of newmasks) is repeated iteratively until fitness (defined asmedian error between
predicted and observed specificity profiles) cannot be improved any further (i.e., convergence is reached).
Residues scoring high in the optimized specificity masks will be considered candidate DoS. For further details on this procedure, please refer to Supplemental
Experimental Procedures.
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specificity masks are used at every generation, 250,000 models
were explored in the kinome-wide search for the most informa-
tive masks. By repeating this algorithmic deployment indepen-
dently ten times with arbitrary initial conditions, 2,500,000
models were explored in total. The high number of models
explored and the fact that the independent evaluations converge
on their solutions imparted confidence that the results obtained
could be close to the ‘‘true mask’’ of specificity.
In order to further benchmark our approach, we collected an
inclusive ‘‘golden list’’ of residues that had been suggested or
predicted as DoS (Table S1) in the literature covering a variety
of methods and species (Brinkworth et al., 2003; Hanks and
Hunter, 1995; Johnson et al., 1998; Mok et al., 2010; Nolen
et al., 2004) and explored the possibility that the best masks
would be enriched in this set of ‘‘golden’’ determinants. Indeed,
Figure S3 shows that, while the distributions over specificity
scores of previously reported DoS and other residues are
probabilistically equivalent at the start of the optimization pro-
cess, they are remarkably different at the end of it, supporting
the aforementioned enrichment (Fisher’s exact test one sided,
p = 8.4 3 107).
In addition to identifying candidate DoS, our approach can
predict the domain specificity (PSSM) of every kinase in the hu-
man kinome from sequence alone. Therefore, we could compare
these to those kinases where the specificity profile has previ-
ously been experimentally determined (Miller et al., 2008) and
assess the algorithm’s predictive accuracy (Figure S2). As
shown in Figure S2, KINspect presents better sequence-speci-
ficity predictive capabilities for some families (e.g., CK1 group)
than others (e.g., STE group), likely reflecting both biological dif-
ferences and algorithmic preferences (for instance, particular
family differences in specificity that could not be captured by
our kinome-wide specificity masks). Finally, for a small set of
kinases used as a ‘‘gold standard’’ in the DREAM challenge (Ellis
and Kobe, 2011) and that, importantly, were not part of our
training set, we could confirm that overall KINspect performed
better than other methods (Figure S3).
While the results in Figure S3E confirm enrichment in previ-
ously reported DoS, it is also important to note that KINspect
identified a large number of additional DoS that had not been
reported in the literature (e.g., 82 alignment positions above
the arbitrary threshold of having a KINspect score above 0.8).
Thus, we set out to evaluate the likelihood that these newly iden-
tified residues would be true DoS. Following up on our initial
reasoning, we hypothesized that by identifying true DoS (the ki-
nase domain residues that truly encode for the domain’s speci-
ficity) one should be able to observe better correlations between
kinase sequence and kinase specificity, by limiting the compar-
ison to this specific set of residues. Indeed, Figure 3A illustrates
how limiting the comparison to those residues that obtained
higher KINspect scores not only maintains, but, in fact, improves
the sequence-to-specificity correlation by approximately 20%
(as compared to the Spearman correlation obtained by consid-
ering the entire domain). Furthermore, we could confirm that
other similarly small groups of residues, such as the set of previ-
ously reported DoS, or other selection strategies, such as resi-
dues close to the substrate, do not lead to similar improvements
of the sequence-to-specificity correlation (Figure 3A; Figure S4).
We next selected a group of residues predicted by KINspect
to be DoS and devised PSPL experiments to experimentally vali-
date their involvement in specificity. In particular, as shown in
Figure 3B, for our first experiment we selected two of the candi-
date DoS predicted by KINspect (named aC1 and aC3 as they
are located on the first and third residues of the aC helix of the
kinase domain) with scores of 1.0 and 0.95 that are in close
proximity to residue P+2 in the peptide substrate. Next, since
PKCg has a strong preference for Arg and Lys at P+2 that had
so far defied structural analysis, we mutated the aC1 and aC3
residues on PKCg from the wild-type aspartates to alanines.
As shown in Figure 3C (and Figure S4), the mutant form main-
tained the Arg preference but lost its Lys preference at this
particular position, at the same time gaining preference for
aromatic residues, thereby validating the specificity determining
nature of these DoS predicted by KINspect.
For our second experiment, we selected a position (named
APE-7 as it is located seven residues before the APE motif
delimiting the activation segment) with a score of 0.75 in close
proximity to residue P+1 (Figure 3B). Similar to the case of
PKCg in theaC1andaC3 residues, Pim1 features an unexplained
strong preference for Gly on position P+1, which is unusual for a
kinase belonging to the CAMK family. Thus, we mutated Pim1
from its wild-type Asp to Cys, a residue more typically seen in
other CAMK kinases, hypothesizing that if this single substitution
could abrogate this Gly preference on position P+1, it would
prove the specificity driving nature of the APE-7 residue. As
shown in Figure 3C (and Figure S4), indeed this single-point
mutation on Pim1 leads to a shift away from P+1 Gly preference
to a non-specific profile similar to that of other CAMKs.
Taken together, these results demonstrate that KINspect
successfully identified a set of residues on which the specificity
of the entire domain is encoded.
The Determinants Form Sparse Networks of Residues
that Together Encode Specificity
In order to evaluate the relationship between the different DoS, as
well as between the DoS and the peptide substrate, we investi-
gated their spatial distribution in the kinase domain. Figure 4
and Movie S1 show the tertiary structure of the DoS identified
by KINspect (alignment positions above the arbitrary threshold
of having aKINspect score above 0.9 across ten independent de-
ployments of KINspect) and offers two interesting observations:
First, we note that several of the determinants localize rela-
tively far from the peptide substrate. However, most of these
distant DoS seem coupled to other DoS through ‘‘canals’’ (i.e.,
existing structural paths connecting the different DoS among
each other and ultimately with the substrate) that eventually con-
tact the substrate peptide, as shown, for instance, in Figures 4B,
4C, or 4J. Such distribution of residues in networks spanning
different domain sites and the presence of these ‘‘canals’’ sug-
gest that specificity could possibly be encoded by groups of
residues that communicate from different parts of the domain,
perhaps in a similar manner to which other domains are regu-
lated allosterically through protein sectors (Reynolds et al.,
2011).
Second, closer inspection of the results (Figure 4; Movie S1)
suggests the presence of three clusters of DoS that, while
Cell 163, 187–201, September 24, 2015 ª2015 The Authors 191
AB
C
(legend on next page)
192 Cell 163, 187–201, September 24, 2015 ª2015 The Authors
connected by other residues that (to a lesser extent) are also
likely to contribute to specificity, are located on different
patches of the kinase domain: cluster 1, while mainly containing
residues from the bigger C-lobe (the lobe best described in
terms of its importance for kinase specificity), also spans resi-
dues from the N-lobe and contacts directly with, and to a large
degree encapsulates, the substrate peptide. This could be
considered the main cluster directly driving specificity and in-
cludes several of the residues and structural features previously
linked to specificity (e.g., the activation segment or the P+1
loop; Nolen et al., 2004), as well as new ones, such as the res-
idues in the aC helix that we experimentally validated to encode
specificity. Cluster 2, on the other hand, is comparably smaller
and contains exclusively residues belonging to the big C-lobe
of the domain. Given its position, we suggest that this cluster
of residues could affect specificity by closing (or opening) the
domain inward (or outward), effectively modifying the size and
shape of the binding pocket, especially on the region that con-
tacts the N-terminal section of the substrate peptide. Finally,
cluster 3, containing very few residues of the small N-lobe,
seems to contribute to specificity by causing subtle structural
re-arrangements leading to differences in the opening and clos-
ing of the lobe onto the peptide. Overall, while all three clusters
simultaneously encode specificity on different parts of the sub-
strate peptide, by shaping the active site in a cumulative and
non-linear fashion, cluster 1 appears to be the main driver of
specificity (Figure S4).
Domain and Specificity Evolution
We next set out to explore whether evolutionary insights could
be derived from these results. It has previously been observed
that the evolution of the kinase domain as a whole is not an
accurate reflection of how different kinases have evolved
different peptide specificities (Miller et al., 2008; Rausell et al.,
2010). Thus, we speculated that a Dendrogram based solely
on residues identified as DoS by KINspect could carry significant
differences compared to a domain-wide phylogenetic tree.
Indeed, Figure 5A (and Figure S5) illustrates how the relation-
ships between kinases (and even between kinase families)
appear to deviate when addressed from the DoS’ perspective.
This DoS-based tree (Figures 5A and S5) illustrates interesting
differences including: (1) the embedding of kinase families within
other families, such as in the case of the PKN family, embedded
within the PKC family, (2) clustering of seemingly unrelated
families, such as the Yank and GRK families, or (3) the splitting
of families in two sets displaying marked amino acid differences
on their DoS, such as in the case of the Ste20 family.
Thus, this analysis provides further proof and explanation as to
how and why the evolution of the entire domain does not always
parallel specificity evolution (Capra et al., 2012). Using the DoS-
based Dendrogram (based on the DoS residues predicted by
KINspect), we have provided an alternative evolutionary expla-
nation of the human kinome, which we argue, more accurately
reflects functional diversity and specificity evolution. Such a
view, of proteins evolving new specificities by diverging at
specific sites within protein domains, is supported by other
recent studies conducted on bacterial signaling networks (Capra
et al., 2012; Skerker et al., 2008).
Kinase Specificity, Regulation, and Activity Are Loaded
onto Different Residues
With the aim of interpreting our results from a more global
perspective, we investigated to what extent the DoS residues
identified by KINspect can interplay with residues known to be
involved in the catalytic activation and regulation of the kinase
domain.
Two independent sets of residues playing such crucial roles
have been identified forming hydrophobic interactions at the
core of the domain and stabilizing the active conformation of
the domain (Kornev et al., 2006, 2008). These two networks of
residues, critical for activation and regulation, are named the cat-
alytic and regulatory spines, respectively. In order to examine
how the DoS interact with the two spines (Figure 5B), we visual-
ized the residues forming the catalytic and regulatory spines as
well as those identified as DoS in the same kinase structure (Fig-
ure 5C). This representation shows that both groups are virtually
mutually exclusive, with kinase domain residues belonging to
either spines or the DoS set (mostly localized on the surface of
the domain), but rarely both.
Despite this apparent separation of biological functions in the
kinase domain, it is at the same time equally important to high-
light that KINspect, in agreement with previous observations
(Nolen et al., 2004), identifies the activation segment as playing
a critical role in specificity. Since this segment also plays a
crucial role in regulation and catalysis by stabilizing the R-spine
(Kornev et al., 2006, 2008), in spite of the apparent general de-
coupling of these different functions, on this particular segment,
they still appear to be partially intertwined (Figure 5C). Moreover,
highlighting the distinct evolutionary and functional paths of
these sets of residues, we could quantify their differences in
Figure 3. Computational and Experimental Validation of the DoS Identified by KINspect
(A) Scatterplots comparing pairwise relationships between kinases’ domain sequences, and their specificity profiles can illustrate the lack or existence of
correlation between sequence and specificity. By limiting the comparison to specific sets, one can investigate whether such sets encode for specificity (i.e.,
maintain or increase the correlation), asmeasured by Spearman’s correlation coefficients. By comparing the correlations obtained from different sets of residues,
the whole domain on the left, previously reported determinants of specificity in the middle and KINspect scores on the right, we confirm that residues with a high
KINspect score encode for specificity (e.g., residues scoring above 0.9 lead to very high sequence-to-specificity correlation, with a Spearman’s correlation
coefficient of 0.69, despite representing only 5.73%of the residues in the kinase domain alignment). Further comparisonswith other sets of residues can be found
in Figure S4.
(B) Three new candidate determinants of specificity predicted by KINspect, positioned in the first and third residues of the aC helix and seven residues before the
APE motif delimiting the activation segment, are experimentally verified to encode specificity by PSPL as described in Experimental Procedures.
(C) Experimental results for the PKCg and PIM1mutants showing a specificity switch for P+2 and P+1 substrate positions, as shown inmatrix and logo form (logos
generated using Seq2Logo; Thomsen and Nielsen, 2012). Complete PSSMs describing the PSPL results for wild-type and mutant kinases can be found in
Figure S4.
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Figure 4. Determinants of Specificity in the Human Kinase Domain
(A) Mesh representation of the kinase domain, including its secondary structure in cartoon representation and a bound peptide substrate colored in orange.
Positions predicted as DoS by KINspect (i.e., residueswith a KINspect specificity importance score higher than 0.9) are highlighted in cyan and the three ‘‘canals’’
formed by these determinants are outlined by red arrows.
(legend continued on next page)
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sequence conservation and conclude that DoS are typically
residues with considerably lower conservation than the highly
conserved spines and many other residues in the domain
(Figure 5D).
Similarly Sparse Networks of Determinants Drive
Specificity in the SH2 Domain
To investigate the generality of these observations, we explored
DoS patterns in another signaling modular protein domain,
namely, the SH2 domain. Following a very similar approach
as described for the kinase domain, and after identifying the
required parameters (Figure S6) appropriately, KINspect identi-
fied several SH2 residues that are likely involved in peptide spec-
ificity (Figure 6; Movie S2).
Being a smaller domain of typically approximately 100 resi-
dues (as can be appreciated in the SH2 domain alignment in
Data S4) and generally showing less variability in peptide spec-
ificity, it is perhaps not surprising that KINspect converged
considerably faster for the SH2 domain (Figure S6) than in the
case of the kinase domain.
Despite this difference, as with the kinase domain, indepen-
dent deployments of KINspect led to the highly reproducible re-
sults (Figure S6), and the general model of peptide specificity
observed in the kinase domain, where a sparse network of
DoS involving a relatively larger number of residues, was also
observed in the case of the SH2 domain (Figure 6; Data S5). Simi-
larly, whereas some DoS were close to the peptide (e.g., Figures
6C, 6D, and 6G), others were relatively far away from it (e.g.,
Figures 6E and 6I), though often connected by inter-residue
‘‘canals.’’ The aforementioned control experiments, where uni-
form and randomized domain-specificity sets were used (Fig-
ure S3), exclude the possibility that the similarities between
these results for the kinase and SH2 domains emanate from
some intrinsic bias in our computational approach. The spatial
representation for several of our DoS is also supported by previ-
ous studies of SH2 domains (Halabi et al., 2009; Lenaerts et al.,
2008). All in all, this suggests that our findings, with a high
number of DoS residues located away from the substrate,
far from being unique to kinase specificity could be a more
general trend applicable to other modular protein domains
(Tompa et al., 2014).
DISCUSSION
Despite the crucial importance of signaling fidelity in biological
organization and cellular responses to environmental cues, our
perception of how peptide specificity is encoded in the kinase
domain has been highly fragmented and biased toward certain
kinase families, non-human species, or a subset of kinase
domain residues (e.g., those close to the peptide substrate).
Here, we developed a data-driven systematic approach to inves-
tigate the presence of DoS residues throughout the human ki-
nome, experimentally validated several of these DoS, which
together with those shown in the accompanying article (Creixell
et al., 2015) encode specificity for the five residue positions most
critical for specificity in the peptide substrate (P-3, P-2, P0, P+1,
P+2), and identified a distributed, but interconnected, network of
DoS in different parts of the kinase domain. In contrast to previ-
ous studies, our results suggest specificity is driven by a larger
number of residues and a more distributed network of typically
non-conserved sets of residues than previously appreciated
(Figures 7A and 7B).
Determinants in the Context of Spines and Sectors
The sparse networks of DoS also present interesting implications
when compared and contrasted with previous work.
First, as mentioned earlier and illustrated in Figure 5, we note
an apparent discrepancy between the residues we identify as
DoS, mostly localized on the surface of the domain, and the
core residues that form the catalytic and regulatory spines (Kor-
nev et al., 2006, 2008). Whereas this suggests some degree of
functional and evolutionary separation between catalytic activity
(and regulation thereof) and peptide specificity, a separation of
functions that is similar to those employed in other signaling
systems (Goldman et al., 2014), our results also indicate that
the activation segment provides a link between these biological
functions. The fact that different functions seem to be ‘‘co-
loaded’’ on this segment could explain why a large fraction of
cancer mutations perturb this critical part of the kinase domain
(Dixit et al., 2009; Creixell et al., 2015).
Moreover, this separation of function, together with our finding
of very different evolutionary speeds and trajectories for spines
and DoS, makes us speculate that kinases have evolved within
tight constraints around spines, where maintaining spine integ-
rity was critical to retain kinase activity. On the other hand, the
more loose constraints on DoS have facilitated the evolution of
new kinases with distinct specificities, a view that is consistent
with the current understanding of the evolution of signaling sys-
tems (Lim and Pawson, 2010).
Furthermore, thepicture portrayedbyour results of sparse net-
works of multiple residues driving specificity together would fit
within the scope of more recent theories on protein function,
namely, the so-called protein sector model. According to this
model, protein function is often encoded in protein sectors,
defined as subsets of co-evolving residues (Halabi et al., 2009;
Lockless and Ranganathan, 1999) identified in different protein
domains, which often also include long-range interactions be-
tween distant residues by allosteric regulation (Reynolds et al.,
2011). Our results suggest that similar mechanisms could be at
work determining specificity in both the kinase andSH2domains.
Perspectives
Despite the significant conceptual and analytical leap forward
provided by KINspect in terms of capability and coverage,
continued experimental and computational advances will make
it even more precise and accurate in the future.
(B–K) For a more clear representation of different parts of the structure, longitudinal (B–F) and transversal (H–K) slices were taken through the kinase domain at
the planes indicated in the inset of (A). A dynamic visualization of this structure can be found in Movie S1. The structure used is that of Akt/PKB in complex with
GSK3 peptide (PDB ID: 1O6K; Yang et al., 2002), and the structural visualization on this and other subsequent figures was generated using Chimera (Pettersen
et al., 2004).
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From an experimental perspective, it is clear that obtaining
peptide specificity profiles for a larger number of kinases
(currently, the percentage of kinases for which their specificity
has been profiled is only about 30% of the whole human kinome)
will only improve our method’s results.
In terms of extending to other applications and expanding
our current approach, KINspect’s methodology could potentially
be applied to several other fundamental biological questions
such as the identification of residues driving kinase inhibitor
binding and specificity. Naturally, we also plan to expand
KINspect to add new peptide-recognizing modular domains
other than the already-included kinase and SH2 domains (e.g.,
SH3 or WW domains) or even include inter-positional depen-
dencies within the substrate peptide in the future when data
become available.
Implications for Evolution and Disease
As introduced earlier, peptide specificity is a crucial component
of a wider cellular requirement, signal fidelity, which ensures
that cells will correctly decode input cues and respond accord-
ingly. Changes in this system have been identified as playing a
critical role in multicellular metazoan evolution (Tan et al., 2009,
2011), but also, at the domain level, in how proteins evolve new
specificities allowing cells to start responding to new cues or un-
fold new responses to them (Capra et al., 2012; Marengere et al.,
1994; Skerker et al., 2008; Zarrinpar et al., 2003). While this has
perhaps been less studied in a disease context, it has been sug-
gested that the same process occurs in cancer (Borrello et al.,
1995; Santoro et al., 1995; Songyang et al., 1995). In the accom-
panying article (Creixell et al., 2015), we utilize the bona fide
DoS described here to identify cancer mutations perturbing
them and experimentally validate their role in causing signaling
rewiring (Creixell et al., 2012) and thus contributing to oncogen-
esis by affecting kinase specificity. We are optimistic these
mutations, and new ones that will be identified in the future, will
constitute a novel and solid foundation for enhanced apprecia-
tion of how signaling networks are perturbed in cancer and other
diseases.
EXPERIMENTAL PROCEDURES
Learning Classifier System
The learning classifier system briefly described in themain text that constitutes
the computational engine behind KINspect is illustrated in Figure 2. Further
algorithmic and mathematical details can be found in Supplemental Experi-
mental Procedures.
Frobenius Distance between Matrices or Vectors
As a measure of dissimilarity between matrices or vectors, the Frobenius
distance or norm can be simply calculated as the square root of the difference
between every value in the two matrices or vectors squared (Ellis and Kobe,
2011).
Domain Information and Alignments
Domain sequences for all human kinase domains and additional information
on the human kinome were obtained from the http://kinase.com/ repository,
with more recent and up-to-date unpublished data kindly provided by
Dr. Gerard Manning (G. Manning, personal communication; Manning et al.,
2002). Similar sequence and domain information was obtained for all the
human SH2 domains from the SH2 domain site (Liu et al., 2006). Sequences
were aligned using ClustalW2 (Larkin et al., 2007), and alignments were further
refined manually with help from Dr. Toby Gibson (EMBL).
Dendrogram Construction
Distance matrices between kinases were computed using BLOSUM62 substi-
tution matrix (Henikoff and Henikoff, 1992). The distances in the kinome tree
are based on all the columns in the alignment, while the distances in the spec-
ificity tree only consider the selected DoS columns in the alignment. We used
neighbor joining to build both trees.
Computing Minimum Distance to Substrate from PDB Files
In a similar manner as described in the accompanying article (Creixell et al.,
2015), we computed ameasure of theminimumdistance between any position
in our alignment and the substrate peptide. This distance was obtained by
extracting distance information from ten representative kinase-substrate
structures deposited in PDB (AKT2 [PDB ID: 1O6K]; Yang et al., 2002, PIM1
[PDB ID: 2BZK]; Bullock et al., 2005, DYRK1A [PDB ID: 2WO6]; Soundararajan
et al., 2013, CDK2 [PDB ID: 2CCI]; Cheng et al., 2006, PAK4 [PDB ID: 2Q0N];
Chen et al., 2014, EPHA3 [PDB ID: 3FXX]; Davis et al., 2009, FES [PDB ID:
3CD3]; Filippakopoulos et al., 2008, EGFR [PDB ID: 2GS6]; Zhang et al.,
2006, IGF1R [PDB ID: 1K3A]; Favelyukis et al., 2001, INSR [PDB ID: 3BU3];
Wu et al., 2008). By developing and deploying in-house python scripts that
utilize the biopython package Bio.PDB, we could extract distance features
between every residue of these kinase-substrate pairs. Subsequently, this
information was collected and, by using the alignment to track the same
position on different kinase-substrate structures, the minimum distance for
each alignment position was obtained. Additional information on substrate
peptide distance for the different mask positions can be found in Data S3.
PSPL Analysis
PKCg (WT and mutant) was produced in HEK293T cells with a 3 3 FLAG
epitope tag at the C terminus and isolated by affinity purification on M2
FLAG antibody resin (Sigma-Aldrich) as described (Mok et al., 2010). Pim1
(WT and mutant) was expressed as an N-terminally hexahistidine-tagged
Figure 5. Evolutionary Aspects of DoS and Their Co-existence with Kinase Spines
(A) As can be observed from the different panels on this DoS-based Dendrogram, where several kinases are localized discordantly with whole-domain evolution,
peptide specificity evolution cannot be directly inferred from whole-domain specificity. These differences highlight how kinases have accumulated mutations on
these specific residues, i.e., DoS, in order to evolve different specificities. For further explanation and information, please refer to Experimental Procedures and
Figures S5.
(B) We next investigated how DoS co-evolved with residues involved in structural changes related to catalysis (kinase spines). As can be seen here, there are
different possible degrees to which DoS and spines could co-exist, ranging from complete overlap (left) to complete exclusion (right). In (C), we investigate which
of these models is more supported by our data.
(C) By comparing the relative localization of the DoS (top-left structure) together with the residues belonging to the catalytic spine (in yellow, bottom-left structure),
the regulatory spine (in red, top-right structure) or all residues together (bottom-right structure), our data suggest that the subgroups of residues that are DoS or
spines are mutually exclusive or, in other words, that residues classified as DoS are not part of the catalytic or regulatory spines. Like in Figure 4A, the structure
used is that of Akt/PKB in complex with GSK3 peptide (PDB ID: 1O6K; Yang et al., 2002).
(D) Evolutionary conservation for the different subsets of residues (whole domain, DoS, C-spine, and R-spine) was computed as the negative of entropy,
using AL2CO algorithm with its default parameters (50), and shown to be significantly lower in DoS compared to the whole domain and the spines (p = 0.014
and p = 1.4 3 106 using Wilcoxon test, respectively).
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fusion protein in E. coli and purified from lysates using TALON resin (Clontech).
Peptide library analysis was performed by arraying a set of 182 peptide mix-
tures (50 mM) in a 1,536-well plate in kinase reaction buffer (2 ml/well). Buffer
for Pim1 reactions was 50 mM HEPES (pH 7.4), 10 mM MgCl2, 0.1% Tween
20, and buffer for PKCg reactions was 50 mM Tris-HCl (pH 7.5), 10 mM
MgCl2, 1mMDTT, 0.1% Tween 20 containing a 5-fold dilution of lipid activator
(EMD Millipore). Peptides had the sequence Y-A-X-X-X-X-X-S/T-X-X-X-X-A-
G-K-K-biotin, in which X positions were generally an equimolar mixture of
the 17 amino acids excluding Ser, Thr, and Cys, and S/T is an even mixture
of Ser and Thr. In each well of the array, the peptide had one of the 20 amino
acids fixed at one of the nine X positions. In addition, two peptides were
included that fixed either Ser or Thr at the phosphoacceptor position. Reac-
tions were initiated by adding kinase (to 8 mg/ml) and [g33P]ATP (50 mM at
0.03 mCi/ml), incubated 2 hr at 30C, and then 200-nl aliquots were transferred
to a streptavidin membrane (Promega). Membranes were washed and dried
as described and exposed to a phosphor screen. Radiolabel incorporation
into each peptide mixture was quantified by phosphor imaging using
QuantityOne software (Bio-Rad). Following background subtraction, data
were normalized so that the average value for a given position within the
peptide was equal to 1. Normalized data from two (PKCg) or three (Pim1) sepa-
rate runs were averaged, log2 transformed, and converted to heatmaps in
Microsoft Excel.
Figure 6. Determinants of Specificity in the Human SH2 Domain
(A) Mesh representation of the SH2 domain, including its secondary structure in cartoon representation and a bound peptide substrate colored in orange.
Positions predicted as DoS by KINspect (i.e., residues with a KINspect score higher than 0.9) are highlighted in cyan.
(B–I) As in the case of the kinase domain, longitudinal (B–E) and transversal (F–I) slices were taken through the SH2 domain at the planes indicated in the inset in
(A). For a dynamic visualization of this structure, please refer to Movie S2. The structure used is that of SAP in complex with SLAM peptide (PDB ID: 1D4T; Poy
et al., 1999).
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